Document Detail


Surgical treatment of doxorubicin-induced heart failure.
MedLine Citation:
PMID:  20072969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Doxorubicin-induced heart failure is a rare, but serious illness and is well-known to be difficult to treat. Prevention strategies have not demonstrated the expected success and unfortunately, this specific type of heart failure does not respond to the usual medical therapies as do other kinds of heart failure. Therefore, surgical procedures may be necessary in some patients. Cardiac transplantation is performed in most cases but this requires cure of the neoplastic disease. This usually requires a recurrence-free interval of several years which is associated with a high attrition rate in these patients due to their cardiac disease. Therefore, ventricular assist devices may be implanted in selected patients as a bridge to transplantation or destination therapy. This review focuses on the surgical options for doxorubicin-induced heart failure and discusses their efficacy as well as their clinical applicability.
Authors:
S Christiansen
Related Documents :
24916009 - Use of a single circuit to provide temporary mechanical respiratory and circulatory sup...
24425419 - Development of a technique for left ventricular endocardial pacing via puncture of the ...
24693039 - Establishment of a rat model of myocardial infarction with a high survival rate: a suit...
16076689 - Increased circulating endothelins are not of cardiopulmonary origin in heart failure pa...
8603129 - Coronary beta-adrenoceptor function is modified by the endothelium in heart failure.
18324939 - Validation of the chinese version of the macnew heart disease health-related quality of...
121799 - Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase.
16502169 - Percutaneous valve replacement: significance of different delivery systems in vitro and...
20545999 - Ventricular asynchrony of time-to-peak systolic velocity in structurally normal heart b...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-01-13
Journal Detail:
Title:  The Thoracic and cardiovascular surgeon     Volume:  58     ISSN:  1439-1902     ISO Abbreviation:  Thorac Cardiovasc Surg     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-14     Completed Date:  2010-03-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7903387     Medline TA:  Thorac Cardiovasc Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  8-10     Citation Subset:  IM    
Affiliation:
Department of Cardiac Surgery, Campus Universit?tsklinikum Schleswig-Holstein, L?beck, Germany. stefanchristiansen@arcor.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibiotics, Antineoplastic / adverse effects*
Doxorubicin / adverse effects*
Heart Failure / chemically induced*,  surgery*
Heart Transplantation
Heart-Assist Devices
Humans
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of lymphatic vessels on the heart.
Next Document:  Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell tr...